 Visanu Wanchai
Concepts (108)
Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Genome | 2 | 2022 | 65 | 0.980 |
Why?
| | DNA, Circular | 1 | 2022 | 18 | 0.850 |
Why?
| | Barrett Esophagus | 1 | 2019 | 30 | 0.640 |
Why?
| | Esophageal Neoplasms | 1 | 2019 | 101 | 0.590 |
Why?
| | Databases, Genetic | 1 | 2017 | 88 | 0.580 |
Why?
| | Genome, Bacterial | 4 | 2021 | 125 | 0.580 |
Why?
| | Bacteria | 1 | 2017 | 221 | 0.530 |
Why?
| | Adenocarcinoma | 1 | 2019 | 402 | 0.490 |
Why?
| | Multiple Myeloma | 5 | 2024 | 2958 | 0.410 |
Why?
| | Genomics | 4 | 2023 | 287 | 0.330 |
Why?
| | Genome, Viral | 3 | 2022 | 79 | 0.320 |
Why?
| | Monoclonal Gammopathy of Undetermined Significance | 2 | 2024 | 115 | 0.260 |
Why?
| | Tumor Microenvironment | 2 | 2024 | 233 | 0.260 |
Why?
| | Periosteum | 1 | 2024 | 26 | 0.230 |
Why?
| | Escherichia coli | 2 | 2021 | 189 | 0.210 |
Why?
| | Monkeypox virus | 1 | 2022 | 2 | 0.210 |
Why?
| | Eukaryotic Cells | 1 | 2022 | 19 | 0.210 |
Why?
| | Computational Biology | 2 | 2021 | 216 | 0.200 |
Why?
| | Disease Outbreaks | 1 | 2022 | 123 | 0.200 |
Why?
| | Osteocytes | 1 | 2024 | 215 | 0.190 |
Why?
| | Osteoblasts | 1 | 2024 | 451 | 0.190 |
Why?
| | RNA Processing, Post-Transcriptional | 1 | 2021 | 24 | 0.190 |
Why?
| | Base Sequence | 2 | 2017 | 644 | 0.170 |
Why?
| | High-Throughput Nucleotide Sequencing | 1 | 2021 | 171 | 0.170 |
Why?
| | DNA | 1 | 2022 | 542 | 0.170 |
Why?
| | Exome | 1 | 2019 | 46 | 0.160 |
Why?
| | Homozygote | 1 | 2019 | 57 | 0.160 |
Why?
| | Software | 1 | 2021 | 273 | 0.160 |
Why?
| | Genetic Variation | 2 | 2017 | 215 | 0.150 |
Why?
| | Chromosome Mapping | 1 | 2017 | 156 | 0.150 |
Why?
| | User-Computer Interface | 1 | 2017 | 81 | 0.150 |
Why?
| | Microcephaly | 1 | 2017 | 41 | 0.150 |
Why?
| | Phylogeny | 4 | 2021 | 234 | 0.140 |
Why?
| | T-Lymphocytes | 3 | 2024 | 339 | 0.140 |
Why?
| | Pseudomonas | 1 | 2015 | 7 | 0.130 |
Why?
| | Populus | 1 | 2015 | 8 | 0.130 |
Why?
| | Ebolavirus | 1 | 2015 | 7 | 0.130 |
Why?
| | Internet | 1 | 2017 | 258 | 0.130 |
Why?
| | Sequence Analysis, DNA | 3 | 2021 | 238 | 0.120 |
Why?
| | B-Cell Maturation Antigen | 2 | 2024 | 91 | 0.110 |
Why?
| | Mice | 4 | 2024 | 5770 | 0.100 |
Why?
| | Humans | 10 | 2024 | 50251 | 0.100 |
Why?
| | Risk Factors | 1 | 2019 | 3608 | 0.090 |
Why?
| | Animals | 4 | 2024 | 13285 | 0.070 |
Why?
| | Cell Line | 2 | 2021 | 1024 | 0.070 |
Why?
| | Cystatin M | 1 | 2024 | 20 | 0.060 |
Why?
| | Chondrocytes | 1 | 2024 | 41 | 0.060 |
Why?
| | Killer Cells, Natural | 1 | 2024 | 108 | 0.060 |
Why?
| | Myeloid Progenitor Cells | 1 | 2023 | 18 | 0.060 |
Why?
| | X-Ray Microtomography | 1 | 2024 | 77 | 0.060 |
Why?
| | CD8-Positive T-Lymphocytes | 1 | 2024 | 127 | 0.060 |
Why?
| | Single-Cell Analysis | 1 | 2024 | 62 | 0.060 |
Why?
| | Antibodies | 1 | 2024 | 155 | 0.060 |
Why?
| | Nigeria | 1 | 2022 | 10 | 0.050 |
Why?
| | Immunotherapy, Adoptive | 1 | 2024 | 159 | 0.050 |
Why?
| | DNA, Viral | 1 | 2022 | 134 | 0.050 |
Why?
| | Plasma Cells | 1 | 2023 | 223 | 0.050 |
Why?
| | Genetic Speciation | 1 | 2021 | 3 | 0.050 |
Why?
| | Shigella | 1 | 2021 | 6 | 0.050 |
Why?
| | Templates, Genetic | 1 | 2021 | 14 | 0.050 |
Why?
| | RNA, Ribosomal | 1 | 2021 | 20 | 0.050 |
Why?
| | Methyltransferases | 1 | 2021 | 29 | 0.050 |
Why?
| | Adenine | 1 | 2021 | 32 | 0.050 |
Why?
| | RNA, Fungal | 1 | 2021 | 21 | 0.050 |
Why?
| | Nucleotide Motifs | 1 | 2021 | 24 | 0.050 |
Why?
| | RNA, Bacterial | 1 | 2021 | 58 | 0.050 |
Why?
| | Meiosis | 1 | 2021 | 56 | 0.050 |
Why?
| | Escherichia coli Proteins | 1 | 2021 | 56 | 0.050 |
Why?
| | ROC Curve | 1 | 2021 | 233 | 0.040 |
Why?
| | Saccharomyces cerevisiae | 1 | 2021 | 189 | 0.040 |
Why?
| | Neoplasm Recurrence, Local | 1 | 2024 | 633 | 0.040 |
Why?
| | Transcription, Genetic | 1 | 2021 | 370 | 0.040 |
Why?
| | Cell Line, Tumor | 1 | 2023 | 1418 | 0.040 |
Why?
| | Mice, Inbred C57BL | 1 | 2024 | 1823 | 0.040 |
Why?
| | Gene Expression Profiling | 1 | 2023 | 1041 | 0.040 |
Why?
| | Multilocus Sequence Typing | 1 | 2018 | 14 | 0.040 |
Why?
| | Africa | 1 | 2017 | 10 | 0.040 |
Why?
| | Mice, Knockout | 1 | 2021 | 847 | 0.040 |
Why?
| | Asia | 1 | 2017 | 18 | 0.040 |
Why?
| | Selection, Genetic | 1 | 2017 | 23 | 0.040 |
Why?
| | Brazil | 1 | 2017 | 35 | 0.040 |
Why?
| | Codon | 1 | 2017 | 47 | 0.040 |
Why?
| | RNA Stability | 1 | 2017 | 24 | 0.040 |
Why?
| | Gene Dosage | 1 | 2018 | 78 | 0.040 |
Why?
| | Sequence Homology, Amino Acid | 1 | 2018 | 144 | 0.040 |
Why?
| | Bacterial Toxins | 1 | 2018 | 52 | 0.040 |
Why?
| | RNA, Messenger | 1 | 2021 | 1108 | 0.040 |
Why?
| | Adaptation, Physiological | 1 | 2017 | 91 | 0.040 |
Why?
| | Recombination, Genetic | 1 | 2017 | 96 | 0.040 |
Why?
| | Clostridium Infections | 1 | 2018 | 53 | 0.040 |
Why?
| | Pandemics | 1 | 2022 | 567 | 0.040 |
Why?
| | Virulence | 1 | 2017 | 174 | 0.040 |
Why?
| | Amino Acid Sequence | 1 | 2018 | 587 | 0.030 |
Why?
| | Molecular Sequence Data | 1 | 2018 | 793 | 0.030 |
Why?
| | Host-Pathogen Interactions | 1 | 2017 | 135 | 0.030 |
Why?
| | Phosphorylation | 1 | 2017 | 534 | 0.030 |
Why?
| | Mutation | 1 | 2022 | 1296 | 0.030 |
Why?
| | Pseudomonas fluorescens | 1 | 2015 | 4 | 0.030 |
Why?
| | Rhizosphere | 1 | 2015 | 5 | 0.030 |
Why?
| | Pseudomonas putida | 1 | 2015 | 5 | 0.030 |
Why?
| | Plant Roots | 1 | 2015 | 33 | 0.030 |
Why?
| | Comparative Genomic Hybridization | 1 | 2015 | 47 | 0.030 |
Why?
| | Filoviridae | 1 | 2015 | 5 | 0.030 |
Why?
| | Pseudomonas aeruginosa | 1 | 2015 | 73 | 0.030 |
Why?
| | Bacterial Proteins | 1 | 2018 | 376 | 0.030 |
Why?
| | Female | 2 | 2024 | 26668 | 0.020 |
Why?
| | Pregnancy | 1 | 2017 | 2605 | 0.020 |
Why?
| | Male | 1 | 2024 | 25483 | 0.010 |
Why?
|
|
Wanchai's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically based on a person's publications. Keywords from attributed publications are matched to keywords from the MeSH. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|